Literature DB >> 6873171

Catecholamine mechanisms in the stimulation of mouse locomotor activity by nitrous oxide and morphine.

M D Hynes, B A Berkowitz.   

Abstract

Nitrous oxide, like morphine, produces a significant increase in mouse locomotor activity. This stimulation of locomotor activity is antagonized by the narcotic antagonist naloxone (10 mg/kg). The catecholamine synthesis inhibitor alpha-methyl-p-tyrosine (300 mg/kg) also significantly reduced the nitrous oxide stimulation of mouse locomotor activity. Administration of naloxone (10 mg/kg) to mice previously treated with alpha-methyl-p-tyrosine resulted in a further decrease in nitrous oxide stimulated activity levels. Haloperidol (0.08-0.64 mg/kg), a potent dopamine receptor antagonist, dose dependently reduced the activity stimulation resulting from exposure to nitrous oxide. Administration of haloperidol (0.08 mg/kg) in conjunction with naloxone (10 mg/kg) further reduced the nitrous oxide effect. In view of the fact that morphine's activity stimulating effects are reduced by alpha-methyl-p-tyrosine and haloperidol, the results reported here suggest additional similarities in the pharmacology of morphine and nitrous oxide. The stimulation of mouse locomotor activity produced by nitrous oxide appears to be mediated by both endogenous opioid and catecholamines.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6873171     DOI: 10.1016/0014-2999(83)90220-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  The effect of age on the behavioral responses of mice following diazepam and midazolam sedation in combination with nitrous oxide.

Authors:  S H Press; G Condouris; M Houpt
Journal:  Anesth Prog       Date:  1995

2.  Effects of morphine on the plus-maze discriminative avoidance task: role of state-dependent learning.

Authors:  C L Patti; S R Kameda; R C Carvalho; A L Takatsu-Coleman; G B Lopez; S T Niigaki; V C Abílio; R Frussa-Filho; R H Silva
Journal:  Psychopharmacology (Berl)       Date:  2005-12-10       Impact factor: 4.530

3.  Selective blockade of N-methyl-D-aspartate channels in combination with dopamine receptor antagonism induces loss of the righting reflex in mice, but not immobility.

Authors:  Nobuhito Kikuchi; Masahiro Irifune; Yoshitaka Shimizu; Keita Yoshida; Katsuya Morita; Takashi Kanematsu; Norimitsu Morioka; Yoshihiro Nakata; Norio Sakai
Journal:  Psychopharmacology (Berl)       Date:  2014-05-31       Impact factor: 4.530

4.  Opiate addiction in adult offspring through possible imprinting after obstetric treatment.

Authors:  B Jacobson; K Nyberg; L Grönbladh; G Eklund; M Bygdeman; U Rydberg
Journal:  BMJ       Date:  1990-11-10

5.  Comparison of nitrous oxide, morphine and diazepam effects in the mouse staircase test.

Authors:  R M Quock; J A Wojcechowskyj; D E Emmanouil
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Neurochemical studies of narcosis: a comparison between the effects of nitrous oxide and hyperbaric nitrogen on the dopaminergic nigro-striatal pathway.

Authors:  N Turle; A Saget; B Zouani; J J Risso
Journal:  Neurochem Res       Date:  1998-07       Impact factor: 3.996

7.  Changes induced by sodium cromoglycate in brain catecholamine turnover in morphine dependent and abstinent mice.

Authors:  O San-Martín-Clark; B Cuéllar; J De Alba; J C Leza; P Lorenzo
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

8.  Benzodiazepine receptor mediation of behavioral effects of nitrous oxide in mice.

Authors:  R M Quock; D E Emmanouil; L K Vaughn; R J Pruhs
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Anxiolytic effects of nitrous oxide in mice in the light-dark and holeboard exploratory tests.

Authors:  D A Czech; D A Green
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Nitrous oxide anxiolytic effect in mice in the elevated plus maze: mediation by benzodiazepine receptors.

Authors:  D E Emmanouil; C H Johnson; R M Quock
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.